FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Ezetimibe and Simvastatin Tablets 10mg/80 mg Recall

Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufacture…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Jan 30, 2019
Recall ID
D-0389-2019
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Ezetimibe and Simvastatin Tablets 10mg/80 mg starting Jan 15, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0389-2019 on Jan 30, 2019. Reason: Presence of Foreign Substance: Product complaint of black speckles observed on tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Product complaint of black speckles observed on tablets.

Product description

Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10

Lot numbers, UPCs & expiration codes

Lot #: 43E021 and 43E023, Exp. 01/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0389-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 15, 2019
FDA report date
Jan 30, 2019
Quantity
118 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0389-2019, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
81936
Address
107 College Rd E
Code information
Lot #: 43E021 and 43E023, Exp. 01/2020
Postal code
08540-6623
Report date
Jan 30, 2019
Product type
Drugs
Recall number
D-0389-2019
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
118 bottles
Termination date
Mar 3, 2020
Reason for recall
Presence of Foreign Substance: Product complaint of black speckles observed on tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10
Distribution pattern
Nationwide within the United States
Recall initiation date
Jan 15, 2019
Initial firm notification
Letter
Center classification date
Jan 22, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0389-2019, published Jan 30, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls